Skip to content

To compare the effects of training using single task & dual task on walking, balance & mental function in Parkinsons disease

Comparison of single task training and dual task training on gait balance and cognitive function in Parkinsons disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054359
Enrollment
38
Registered
2023-06-23
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G20- Parkinsons disease

Interventions

Intervention1: Dual task training: 30 minutes of simultaneous gait and cognitive training three days a week for 6 weeks Intervention2: Single task training and dual task training: Single task trainin

Sponsors

ABVIMS and Dr RML Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed case of idiopathic Parkinsonâ??s disease 2. Both gender 3. No change in medication during the study 4. Exhibiting no cognitive impairment 5. Hoehn &Yahr stage II and III 6. Ability to ambulate 300 feet with or without an assistive device 7. No other neurological condition 8. Willing to participate in the study

Exclusion criteria

Exclusion criteria: 1. Deep brain stimulation 2. Inability to follow 2-step commands 3. Postural hypotension 4. Vestibular disorders 5. Psychiatric diseases

Design outcomes

Primary

MeasureTime frame
Improvement in gait & balance by 6 minute walk test, Timed up and go test, Berg balance test and cognitive function assessment by Montreal cognitive assessment Timepoint: Baseline, 6 weeks & 12 weeks

Secondary

MeasureTime frame
Unified Parkinsons Disease Rating ScaleTimepoint: Baseline & 12 weeks

Countries

India

Contacts

Public ContactMarlin T Abraham

Guru Gobind Singh Indraprastha University

shipc76@gmail.com9810632919

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026